Tech excites us – and if you’re taking your business to the next level through tech transactions, you need our knowledge of the technology itself as well as corporate expertise. Your company will be more successful when it maximises the value of technology and IP – a cornerstone of our practice.
To succeed in today’s fast-paced business environment you need advisers that bring a commercial outlook and market perspective from the get-go. Our focus on pre and post-transaction aspects such as planning and post-merger integration leave no stone unturned.
We believe in practical, proactive advice with a personal touch. Our 200 lawyers across Europe, Asia and the Middle East advise on all forms of corporate finance from private and public M&A, to private equity, IPOs and joint ventures together with all of the corporate governance and company advice needed.
We use tech solutions to underpin smart, useful advice that benefits our clients – not for the sake of it.
Whatever your size, stage in lifecycle or sector you’ll benefit from having our talented deal-makers onboard.
If you would like to know more about working with us, please contact Co-Heads Peter Veranneman in Germany and Stefano Silvestri in the United States.
Legal 500 2018 EMEA
Chambers 2017 Latin America
Legal 500 2017 UK
Chambers UK 2017
Legal 500 EMEA
Given increased adoption of new technology for payment systems and within the financial ecosystem, the relevant authorities in Singapore have provided guidelines to mitigate cybersecurity risks. Despite adopting ...
With the spate of cybersecurity incidents on large listed companies, cybersecurity risk has increasingly become a key point that affects investor risk appetite and companies are now subject to certain disclosure ...
Bird & Bird assisted the Swedish Addtech Group during the M&A process of all shares outstanding in the Danish company Thiim A/S on 12 June 2019.
International law firm Bird & Bird teamed up with more than 10 law firms to scale up solar power as part of the Open Solar Contracts initiative, launched on 13 June 2019 at the African Energy Forum in Lisbon, Portugal
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
International law firm Bird & Bird advises the FUJIFILM group on the acquisition of German medwork GmbH, a company that develops, manufactures and markets instruments for therapeutic and diagnostic endoscopy.
There are no forthcoming events for this area. Please click on the button below to view past events.
Does access to data require a new approach in antitrust aftermarket cases? What are the new European vehicle CO2 em… https://t.co/a5hMjuMrbf
How have you used data to transform your business? We caught up with our speakers Andrew Radley, BD Director at… https://t.co/XqTWqw3Ily